Forging a Path Using Momentum and Determination―Choosing Entrepreneurship to Take on ALS Drug Discovery――Yoshiho Ikeuchi (UTokyo-IIS) × Jiro Kawada (Jiksak Bioengineering, Inc.)――
At #UTokyo_IIS , all professors, associate professors and lecturers independently lead their own laboratories. When Yoshiho Ikeuchi joined #UTokyo_IIS as a lecturer in 2014, he sat alone in his newly established lab and was carefully mapping out his future research plans. One day, he received a visit from Jiro Kawada, a postdoctoral researcher at #UTokyo_IIS who aspired to develop medication for amyotrophic lateral sclerosis (ALS). Together, they launched a research project that merged neuroscience and engineering, which eventually lead to the biotech startup Jiksak Bioengineering.Eight years have passed since the company's founding. The young CEO Jiro Kawada is devoted wholeheartedly to drug discovery, and Professor Yoshiho Ikeuchi works alongside him as a technical advisor while also continuing his academic research. Their conversation hinted at a wide range of career possibilities, not only for PhD holders but also for those with master's and bachelor's degrees.